In this conference you will get to know the relevant aspects of risk mitigation with respect to potential Nitrosamine contamination in drug substances and drug products. Dr. Hiltrud Horn will discuss what has to be considered for manufacturers and what are potential sources of Nitrosamines. You will also see a practical example of risk assessment.

For more information please visit the following website:
https://www.gmp-navigator.com/seminare/gmp-seminar-konferenz/nitrosamine-impurities

(Conference organized by Concept Heidelberg)

HORN Pharmaceutical Consulting
CMC – GMP – Regulatory Affairs
Dr. Hiltrud Horn
Am Alten Schloß 1
D-76646 Bruchsal
Germany

Phone: +49 (0) 7251/305 527
Fax: +49 (0) 7251/305 528
Mobile: +49 (0) 160/5834 213
e-mail: info@horn-pharma.de
Internet: www.horn-pharma.de